Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 20-year-old woman had stable Progressive Hemifacial Atrophy and Vitiligo after treatment, suggesting a possible link between the conditions.

Nonsegmental vitiligo is caused by the immune system attacking skin cells, often linked to other autoimmune diseases.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

A 13-year-old boy had both lichen planus and vitiligo, suggesting a possible link between the two conditions.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Some people with the skin color loss condition, vitiligo, also develop the skin inflammation condition, lichen planus, possibly due to local trauma, sun damage, or genetic factors.

The meeting concluded with optimism about increasing research and better management of vitiligo.

Vitiligo often runs in families and is linked to genetics and autoimmune factors.

Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

Ultraviolet light treatment with trioxsalen was ineffective for vitiligo in the cases described.

The 2-step surgery effectively treats stable follicular vitiligo with high patient satisfaction and no major complications.

Vitiligo causes white skin patches, often starts before age 20, and is linked to other health issues.

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Vitiligo is caused by the immune system attacking skin pigment cells.

Vitiligo may be linked to stopping finasteride.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

A new mouse model effectively mimics vitiligo for research and drug testing.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

A woman developed vitiligo from repeated eyebrow microblading.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Diphencyprone therapy for hair loss can cause vitiligo.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.